Project Aims to Remove Barriers to Care to Help Prevent Vision Loss Today, the American Diabetes Association ® (ADA) and Genentech, a member of the Roche Group, announced a new partnership as part of the ADA’s Health Equity Now work to tackle access to screening and treatment for eye diseases that affect the diabetes community. Diabetes is the leading cause of vision loss in people 18–64 years old, and African Americans, American Indians, Alaska Natives, Hispanics/Latinos, and older adults living with diabetes are at higher risk of losing their vision or going blind. 1 Comprehensive eye exams